A new study investigates how POGZ, a protein linked to White-Sutton syndrome, functions in thyroid cancer (THCA). Researchers found that POGZ expression is reduced in thyroid cancer tissues and that it suppresses cancer cell growth and movement by interacting with the protein MAD2L2. The study also identified a regulatory chain — involving a long noncoding RNA (LINC01355) and a microRNA (miR-27b-3p) — that controls POGZ levels in these cancer cells, with findings confirmed in mouse tumor models. This is the first reported noncoding RNA network centered on POGZ in thyroid cancer, pointing toward potential new therapeutic targets.